Local state governments were notified by the Centers for Disease Control and Prevention to begin preparations for possible mass distribution of a Covid vaccine first thing in November.
A private letter was sent to a lot of governors last August 27, and in that letter, it was apparently mentioned that the agency sealed a deal with healthcare firm McKesson Corporation, which will supply the vaccine to medical facilities and health care establishments.
CDC Director Dr. Robert Redfield seeks assistance from the local governments for the upcoming distribution which will mainly be facilitated by McKesson. The primary request is for the state governments to loosen reins on the regulatory requirements for the opening of distribution sites, to eliminate possible hindrances that could slow down the process when it comes.
A document citing several strategies for different vaccination scenarios addressed to state officials. Details about vaccines - its distribution and administration - are laid out in the document.
There is still no absolute certainty about the availability of a vaccine by the scheduled date, but a fact is that the date is set just two days before the national elections.
The Head Commissioner of FDA says that the agency is open to fast-track the approval of a Coronavirus vaccine if the developer requests so. The preferred time to submit an application would be before Phase Three ends according to Dr. Stephen Hahn, head of the agency.
The most likely candidate for such a case would be AstraZeneca’s AZD-1222, which recently began the third phase of its clinical trials after a sequence of positive results. Other similarly-promising vaccines under trials are the ones of Moderna and Pfizer.
NIH Director, Dr. Anthony Fauci, expects a vaccine to be ready by the end of this year, and mass vaccination efforts would be started by 2021. He expressed his reluctance on the November 1 schedule but is also not entirely opposed to the idea as long as it was sure to be safe and effective. Many drugs have previously been given the emergency use authorization lately for Covid-19 management and so far there has not been any negative feedback so it is safe to say that the drugs that are being granted for approval are guaranteed to be beneficial than risky.